GMO Small Cap Quality III

GMO Small Cap Quality III

GMAWX
GMO Small Cap Quality IIIUS flagNASDAQ
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
GMO Small Cap Quality III (GMAWX) is an institutional mutual fund managed by Grantham, Mayo, Van Otterloo & Co. LLC (GMO), focusing on long-term capital appreciation through investments in high-quality small-cap U.S. equities. The fund employs a quality-oriented strategy that emphasizes companies with strong balance sheets, consistent profitability, high returns on capital, and sustainable competitive advantages; it typically holds a concentrated portfolio of 50-100 stocks selected from the Russell 2000 Index universe, with sector allocations dynamically adjusted based on GMO's proprietary multi-factor models incorporating valuation, profitability, and financial stability metrics. Geographically, it targets U.S.-domiciled small-cap companies operating primarily in North America, serving institutional investors such as endowments, foundations, and pension plans seeking exposure to resilient small-cap segments with lower volatility than traditional benchmarks. Launched in 2016 and based in Boston, Massachusetts, the fund operates as part of GMO's broader asset management platform, which oversees approximately $60 billion in assets across equity, fixed income, and alternative strategies as of late 2025. Recent developments include GMO's strategic expansion into enhanced indexing approaches for small-cap quality in 2024, a key team reinforcement with the addition of experienced portfolio managers specializing in factor investing, and alignment with GMO's firm-wide adoption of advanced ESG integration frameworks announced in early 2025 to better address sustainability risks in small-cap portfolios.